Evaluating the Imperative Role of Pre- and Post-eCTD Standards in Dossier Validation: An Inevitable Outlook

Curr Pharm Des. 2024 Apr 15. doi: 10.2174/0113816128301122240403053217. Online ahead of print.NO ABSTRACTPMID:38623971 | DOI:10.2174/0113816128301122240403053217
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Source Type: research